000 | 01228 a2200325 4500 | ||
---|---|---|---|
005 | 20250515065628.0 | ||
264 | 0 | _c20071102 | |
008 | 200711s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0707272 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPodesser, B K | |
245 | 0 | 0 |
_aNitric oxide homeostasis as a target for drug additives to cardioplegia. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cAug 2007 |
||
300 |
_a930-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCardioplegic Solutions _xpharmacology |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 |
_aHomeostasis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 |
_aReperfusion Injury _xphysiopathology |
700 | 1 | _aHallström, S | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 151 _gno. 7 _gp. 930-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0707272 _zAvailable from publisher's website |
999 |
_c17032260 _d17032260 |